From RadiaDyne’s FDA expansion to NuVasive launching its new implants, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. FDA expands indications for RadiaDyne’s OARtrac dose monitor RadiaDyne announced in an Oct. 24 press release that it has received additional FDA clearance for its upcoming OARtrac. The OARtrac allows […]
Varian Medical Systems
Varian launches Halcyon treatment in EU
Varian Medical (NYSE:VAR) said today it launched its Halcyon image-guided volumetric intensity modulated radiotherapy cancer treatment system in the European Union, with the 1st patient being treated in Blegium. The Palo Alto, Calif.-based company said its Halcyon IMRT system features improvements that make it more comfortable for patients and streamline operator’s workflow, only requiring 9 […]
7 medtech stories we missed this week: Sept. 29, 2017
From EOI getting FDA clearance to Sanuwave’s new joint venture agreement, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. EOI wins FDA nod for FLXfit15 expandable cage EOI announced in a Sept. 28 press release that it has received FDA 510(k) clearance for its FLXfit 15. The clearance […]
Varian Medical launches Eclipse 15.5 radiosurgery planning software
Varian Medical (NYSE:VAR) said today it launched the Eclipse 15.5, a new version of its radiotherapy treatment planning software which includes support for its HyperArc high definition radiotherapy system The newly launched Eclipse 15.5 features MCO, which allows clinicians to examine outcomes related to clinical criteria including which organs are spared versus coverage of a targeted tumor, […]
7 medtech stories we missed this week: August 11, 2017
From Xtant Medical’s 510(k) extension to Varian Medical’s distribution deal, here are seven medtech stories we missed this week but thought were still worth a mention. 1. FDA extends Xtant Medical’s 510(k) for Calix C spinal implant Xtant Medical announced in an Aug. 9 press release that the FDA has cleared its product line extensions […]
Varian Medical touts 1st commercial use of its HyperArc system
Varian Medical‘s (NYSE:VAR) said today that the 1st patient has been treated with its HyperArc high definition radiotherapy system at Negrar-Verona, Italy’s Sacro Cuore Don Calabria Cancer Care Center. The Palo Alto, Calif.-based company’s HyperArc system is designed around its TrueBeam and Edge treatment platform, and delivers more compact radiation doses to fully saturate a […]
Accuray touts study data in head-to-head between TomoTherapy and Varian’s RapidArc
Accuray (NSDQ:ARAY) today released data from a prospective study comparing its TomoTherapy intensity-modulated radiation therapy system with Varian Medical‘s (NYSE:VAR), RapidArc radiotherapy system, touting a higher survival rate for patients treated with its TomoTherapy system. Results from the study were published last month in the International Journal of Radiation Oncology – Biology – Physics. Accuray said that […]
Varian Medical wins FDA nod for Halcyon radiotherapy cancer treatment system
Varian Medical (NYSE:VAR) said today it won FDA 510(k) clearance for its Halcyon image-guided volumetric intensity modulated radiotherapy cancer treatment system. The Palo Alto, Calif.-based company said its Halcyon IMRT system features improvements that make it more comfortable for patients and streamline operator’s workflow, only requiring 9 steps from start to treatment, down from 30 steps […]
Avita Medical taps ex-Novartis exec Perry for CEO as it shifts focus to US | Personnel Moves June 9, 2017
Avita Medical (ASX:AVH) said last week it tapped former Novartis (NYSE:NVS) global biz dev & licensing chief scientific officer Dr. Michael Perry as its new chief executive officer, replacing resigning CEO Adam Kelliher. Dr. Perry served as a non-exec director of Avita since Feb 2013, according to the company, and held positions with Novartis including chief scientific […]
Feds charge ex-Medicare employees with insider trading
Former employees at the Centers for Medicare & Medicaid Services used confidential information on Medicare reimbursement changes for radiation treatments and dialysis in a nearly $4 million insider trading scheme, federal prosecutors and the U.S. Securities & Exchange Commission alleged today. An SEC lawsuit and a criminal complaint accuse political consultant David Blaszczak, founder of Precipio Health Strategies […]
Japan approves Varian Medical’s ProBeam proton therapy
Varian Medical (NYSE:VAR) said today it won Shonin approval from the Japanese Ministry of Health, Labor and Welfare for its ProBeam system designed for proton therapy. Proton therapy is designed for precise treatment of certain types of cancer while providing potentially fewer side effects than conventional radiation therapy, the Palo Alto, Calif.-based company said. Varian claims that […]